Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

glucan/kansè

Lyen an sove nan clipboard la
Paj 1 soti nan 29 rezilta yo

Postprandial Glucose, Insulin Responses and Appetite Hormones to Dried Mushrooms

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri

Myeloid-derived Suppressor Cells (MDSCs) in OSCC Patients

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Oral squamous cell carcinoma (OSCC) has the highest annual increase in the rate of death among the top 10 leading cancers in Taiwan. This research aimed to explore whether increased anti-tumor immunity for OSCCs reduces the recurrence rate or improves survival. We first identified

Effects of Lentinula Edodes Bars on Dyslipidemia and Oxidative Stress in Cholesterol Individuals: Randomized Study

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
2.1 Study design The primary outcome of the study was cholesterolemia, as assessed by total cholesterol levels, triglycerides or low-density lipoproteins (LDL) and high-density lipoproteins (HDL). The secondary outcomes included blood glucose, Body Mass Index (BMI) and oxidative stress biomarkers. A

Oat Beta-glucan as a Supplement in Chilean Type 2 Diabetics

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri

Bacillus Calmette-guérin Vaccination to Prevent Infections of the Elderly

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
In an era of antimicrobial resistance, where the already existing antimicrobials are not sufficient, the development of new strategies for the prevention and treatment of infections is of great interest. This approach becomes more and more mandatory in our current era of the financial crisis where

NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri

(PM-01) IMPRIME PGG® With BTH1704 and Gemcitabine for Advanced Pancreatic Cancer

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri

A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
After the screening procedures confirms eligibility: Study Drugs: The participant will receive both Imprime PGG and rituximab weekly, for four weeks. Clinical Exams: At the participant's weekly visit there will be have a physical exam and general health and specific questions about any problems they

Bronchoalveolar Lavage Lateral-Flow Device Test for Invasive Pulmonary Aspergillosis: a Multicenter Study

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Project Outlook Sensitive and specific biomarkers for early diagnosis of IPA are urgently needed to improve survival. In this multicenter study we will evaluate the potential of the novel Lateral Flow Device test for early, bedside diagnosis of IPA. A successful implementation of the studies

Phase I, Dose-Escalation Study of Soluble Beta-Glucan (SBG) in Patients With Advanced Solid Tumors

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri

Lung Cancer Vaccine Plus Oral Dietary Supplement

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Open-label pilot (Phase II) study to assess the immunologic activity of a cellular vaccine composed of killed allogeneic tumor cells (1650-G) and GM-CSF in patients with stage I-IIIA NSCLC after definitive therapy. (Surgery, Surgery plus Radiation Therapy, or Surgery, Radiation Therapy plus Adjuvant

Immune Benefits From Mushroom Consumption

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
A non-therapeutic study is described. This is an intervention study at two levels of mushroom intake. The number of subjects and experimental assays are selected as a pilot study to generate the dose level and the efficacy. Subjects age 21 to 50 will be recruited and provide a baseline blood draw.

Empirical Versus Preemptive Antifungal Therapy

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
OBJECTIVES: Primary - To compare empirical approach (i.e., fever driven) versus preemptive approach (i.e., diagnostic driven), for starting antifungal therapy with caspofungin acetate, in patients with acute myeloid leukemia or myelodysplastic syndrome who are starting chemotherapy (for attaining

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
PRIMARY OBJECTIVES: I. Determine the maximum tolerated dose of PGG beta glucan in combination with alemtuzumab and rituximab. (Phase I) II. Assess the rate of complete response of patients with high-risk, early-intermediate stage CLL who are treated with alemtuzumab, rituximab, and PGG beta glucan

Validation of an Index of Neutropenia (D-index) in Febrile Neutropenic Cancer Patients

Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
Neutropenia is a major risk factor for invasive fungal infections, particularly those caused by moulds, such as Aspergillus spp., Fusarium spp. and the Zygomycetes. Among neutropenic patients, these invasive mould infections (IMI) occur almost exclusively in patients with profound neutropenia (<100
Antre nan paj
facebook nou an

Baz done ki pi konplè remèd fèy medsin te apiye nan syans

  • Travay nan 55 lang
  • Geri èrbal te apiye nan syans
  • Remèd fèy rekonesans pa imaj
  • Kat entèaktif GPS - tag zèb sou kote (vini byento)
  • Li piblikasyon syantifik ki gen rapò ak rechèch ou an
  • Search remèd fèy medsin pa efè yo
  • Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive

Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye

Google Play badgeApp Store badge